Amylin will draw a $165M line of credit from Lilly
This article was originally published in Scrip
Executive Summary
Amylin, in its first-quarter results, reported a slightly narrower loss as the company cut back on costs. The firm also stated that it recently notified partner Lilly of its intent to draw a $165 million line of credit available from the company.